Early effect of agomelatine on general interest in outpatients suffering major depressive disorder: a parallel group, randomised, double-blind, multicentre study

Trial Profile

Early effect of agomelatine on general interest in outpatients suffering major depressive disorder: a parallel group, randomised, double-blind, multicentre study

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Aug 2016

At a glance

  • Drugs Agomelatine (Primary) ; Serotonin uptake inhibitors
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Mar 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 26 Nov 2012 Planned End Date changed from 30 Sep 2012 to 30 Mar 2013 as reported by ISRCTN: Current Controlled Trials.
    • 26 Nov 2012 Status changed from completed to recruiting as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top